OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DNA Repair and Therapeutic Strategies in Cancer Stem Cells
Matthew S. Gillespie, Ciara Ward, Clare C. Davies
Cancers (2023) Vol. 15, Iss. 6, pp. 1897-1897
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Exploring extracellular RNA as drivers of chemotherapy resistance in cancer
Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 2

Molecular Imaging of Cancer Stem Cells and Their Role in Therapy Resistance
Sofia Nascimento dos Santos, Timothy H. Witney
Journal of Nuclear Medicine (2025) Vol. 66, Iss. 1, pp. 14-19
Closed Access | Times Cited: 1

Recent Advancements of Aptamers in Cancer Therapy
Swathi Venkatesan, Kaushik Chanda, M. M. Balamurali
ACS Omega (2023) Vol. 8, Iss. 36, pp. 32231-32243
Open Access | Times Cited: 18

From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7

lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6

Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy
Bemrew Admassu Mengistu, Tirunesh Tsegaw, Yitayew Demessie, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5

Chemoresistance in Pancreatic Cancer: The Role of Adipose-Derived Mesenchymal Stem Cells and Key Resistance Genes
Shahram Parvaneh, Vanda Miklós, Zoltán G. Páhi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 390-390
Open Access

MiRNAs: main players of cancer drug resistance target ABC transporters
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Phase separation of EEF1E1 promotes tumor stemness via PTEN/AKT-mediated DNA repair in hepatocellular carcinoma
Xiaofan Pu, Chaolei Zhang, Junbin Jin, et al.
Cancer Letters (2025), pp. 217508-217508
Closed Access

Exploring the potential of stem cell therapy: Applications, types, and future directions
KeerthiShri Boopathy, Thirunavukkarasu Palaniyandi, Maddaly Ravi, et al.
Acta Histochemica (2025) Vol. 127, Iss. 2, pp. 152237-152237
Closed Access

Tetrahydrobenzimidazole TMQ0153 targets OPA1 and restores drug sensitivity in AML via ROS-induced mitochondrial metabolic reprogramming
Su Jung Park, Claudia Cerella, Jin Mo Kang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 4

Advancements in a novel model of autophagy and immune network regulation in radioresistance of cancer stem cells
Leyao Li, Xin Wang, Mei Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117420-117420
Open Access | Times Cited: 4

An update understanding of stemness and chemoresistance of prostate cancer
Afiya Wahab, Hifzur R. Siddique
Expert Review of Anticancer Therapy (2025)
Closed Access

Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations
Joseph Nhyira Obisi, Abike Ndidiamaka Josephine Abimbola, Oluwasegun Adesina Babaleye, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Photo-Activated Ferrocene-Iridium(III) Prodrug Induces Immunogenic Cell Death in Melanoma Stem Cells
Qiaoshan Lie, Hui Jiang, Xiangwan Lu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access

Multilevel Mechanisms of Cancer Drug Resistance
Małgorzata Roszkowska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12402-12402
Open Access | Times Cited: 3

Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance
RF. Zaarour, Marcelo Lima Ribeiro, Bruno Azzarone, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8

Targeting ABCA1 via Extracellular Vesicle‐Encapsulated Staurosporine as a Therapeutic Strategy to Enhance Radiosensitivity
Qi Yang, Wenyan Gao, Xinyue Li, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 2

Exosomes as a Nano-Carrier for Chemotherapeutics: A New Era of Oncology
Rodrigo Pinheiro Araldi, Denis Adrián Delvalle, Vitor Rodrigues da Costa, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2144-2144
Open Access | Times Cited: 6

Notch-3 affects chemoresistance in colorectal cancer via DNA base excision repair enzymes
Dennis C. George, Fred E. Bertrand, George Sigounas
Advances in Biological Regulation (2024) Vol. 91, pp. 101013-101013
Closed Access | Times Cited: 1

The MDM2–p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem Cells
Yurika Nakagawa-Saito, Yuta Mitobe, Keita Togashi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3948-3948
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top